20-Hydroxylucidenic acid E2 ( 20-羟基赤芝酸E2 )

产品货号. M38475 CAS No. 852567-75-0

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

20-Hydroxylucidenic acid E2
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA .
产品描述

20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.
体外实验

———
体内实验

———
同义词

20-羟基赤芝酸E2
通路

Others
靶点

Other Targets
受体

———
研究领域

———
适应症

———

1. Akihisa T, et al. Oxygenated lanostane-type triterpenoids from the fungus Ganoderma l ucidumJ. Journal of Natural Products, 2005, 68(4): 559-563.

计算器

产品手册

关联产品

Bococizumab

Bococizumab (PF-04950615) 是一种抗-人 PCSK9 的抗体抑制剂，可降低低密度脂蛋白胆固醇 (LDL-C) 水平。Bococizumab 可用于高胆固醇血症的研究。
Tubeimoside I

Tubeimoside I(Lobatoside-H) 是中草药 Bolbostemma papulatum (MAXIM.) 的提取物。
BI-0474

BI-0474 是一种强效的 KRASG12C 抑制剂，其对 GDP-KRAS::SOS1 蛋白-蛋白相互作用的IC50 值为 7.0 nM。BI-0474 对携带 G12C 突变的 NCI-H358 细胞具有较好的抗增殖活性。BI-0474 还在非小细胞肺癌异种移植模型中显示出较好的抗肿瘤活性。